Obesity Drug Shows Promise in Easing Knee Osteoarthritis Pain
A large trial showed that semaglutide, sold as Ozempic for diabetes and as Wegovy for obesity, was better than any current ...
Ozempic and Wegovy considered ‘available’ after more than two years in shortage
The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years ...
MedPage Today6h
Wegovy Reduced Pain From Knee Osteoarthritis
Semaglutide (Wegovy) reduced pain and improved physical function in patients with obesity and knee osteoarthritis, a ...
Landmark Study Finds Life-Altering Benefits for Teens a Decade After Weight Loss Surgery
Researchers have found "tremendous long-term outcomes" for teenagers who underwent surgery to treat their severe obesity a ...
STAT5h
Wegovy reduces knee pain in osteoarthritis patients with obesity, study finds
Wegovy reduced arthritic knee pain in study subjects with high BMI. Unknown: the exact mechanism or whether it would prevent knee replacement surgery.
Hims & Hers stock falls 14% after FDA changes semaglutide supply status (update)
Hims & Hers (HIMS) stock fell 14% following news that Novo Nordisk’s (NVO) weight-loss drug Wegovy is no longer ...
STAT11h
Novo Nordisk’s Ozempic and Wegovy, long in shortage, are now listed as available by FDA
Semaglutide, the scientific name for Novo’s GLP-1 diabetes drug Ozempic and obesity drug Wegovy, has been on the shortage ...
Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study
In humans, nasal foralumab modulates immune responses by inducing regulatory-type T cells. Semaglutide is an effective ...
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
It is a sign that Novo Nordisk’s efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to ...
Ozempic, Wegovy move closer to no longer being in shortage, FDA says
Both Ozempic and Mounjaro are approved by the FDA to treat Type 2 diabetes, but some doctors prescribe the medication "off-label" for weight loss, as is permissible by the FDA.
Semaglutide linked to reduced arthritis knee pain in people with obesity, study finds
People who lost a significant amount of weight with semaglutide saw major improvements in osteoarthritis knee pain, research published Wednesday in the New England Journal of Medicine finds.